For decades, the Biological and Toxin Weapons Convention -- an international treaty outlawing biological weapons -- has gone unchecked. But a report released this week proposes guidelines for trial inspections at U.S. plants that a group of biopharmaceutical industry experts believes could "resuscitate the bioweapons ban." The report was released Nov. 17 by Center for Strategic and International Studies Senior Fellow Amy Smithson and the president of the University of Maryland Biotechnology Institute, Jennie Hunter-Cevera, one of the 14 industry...
